INFUSYSTEM HOLDINGS, INC Operating Lease, Expense
INFUSYSTEM HOLDINGS, INC (INFU) reported Operating Lease, Expense of $400.00 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2020-03-30
- INFUSYSTEM HOLDINGS, INC operating lease, expense for the quarter ending 2019-06-30 was $400.00K.
- INFUSYSTEM HOLDINGS, INC operating lease, expense for the quarter ending 2018-12-31 was $400.00K.
- INFUSYSTEM HOLDINGS, INC operating lease, expense for the quarter ending 2018-09-30 was $400.00K.
- INFUSYSTEM HOLDINGS, INC operating lease, expense for fiscal 2018 was $1.50M.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2019-06-30 | $400.00K 10-Q · filed 2019-08-14 | $700.00K 10-Q · filed 2019-08-14 | ||
| 2018-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $800.00K derived: sum of 2 quarters · filed 2020-03-30 | $1.50M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $400.00K 10-Q · filed 2019-11-14 | $1.10M 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |